healthcare professionals
Studies have been conducted to give you detailed information about alli®. Use the resources below to discover the outcomes.
alli proven to reduce visceral fat, a dangerous fat linked to many life-threatening diseases, according to new data released today
Orlistat for the management of overweight individuals and obesity: a review of potential for the 60 mg, over-the-counter dosage. (PDF)Anderson. Expet Opin Pharmacother
Orlistat in the long term treatment of obesity in primary care settings. (PDF)Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. Arch Fam Med
Weight loss, weight management, and improved cardiovascular risk factors after 2 years of treatment with orlistat for obesity. (PDF)Rossner S, Sjostrom L, Noack R, Meinders AE, Noseda G. Obes Res
Compliance, behaviour change, and weight loss with orlistat in an over-the-counter setting. (PDF)Schwartz SM, Bansal VP, Hale C, Rossi M, Engle JP. Obesity
Dr. Vidhu discusses the safety of alli.
In order to view PDF documents, you must have Adobe® Reader® installed on your computer. If you do not have it, you may download it from the Adobe website.
Adobe and Adobe Reader are registered trademarks of Adobe Systems Incorporated.